Health

Drug-resistant Candida auris infection rates continue to rise

Candida auris, an emerging fungal pathogen resistant to many antimicrobial agents, continues to threaten U.S. public health. Researchers at bioMérieux Inc. conducted a retrospective analysis of blood cultures positive for ...

Diseases, Conditions, Syndromes

Better tests needed to identify Candida auris susceptibility

Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision. That decision relies on susceptibility testing, but commercially available antifungal tests perform ...

Diseases, Conditions, Syndromes

Nirmatrelvir-ritonavir effective for outpatient treatment of COVID-19

For outpatient treatment of COVID-19, nirmatrelvir-ritonavir is effective for reducing 30-day hospitalization or death, while molnupiravir is associated with a reduction in 30-day mortality, according to a study published ...

page 38 from 40